In summary, the current study has shown that loss of NAT1 in breast cancer cells is likely to enhance drug resistance by inhibiting intrinsic apoptosis, possibly leading to the activation of necroptosis as the major cell death pathway. Here, NAT1 is linked to breast cancer.